Skip to main content

IVISbrite A549 Red F-luc Bioluminescent Tumor Cell line (Bioware Brite)

The IVISbrite A549 Red F-luc tumor cell line (Bioware® Brite A549-Red-Fluc) is derived from A549-human lung carcinoma. The cells have been stably transduced with the red-shifted firefly luciferase gene from Luciola Italica (Red F-Luc), for a brighter, red-shifted signal.

For research use only. Not for use in diagnostic procedures.
Part Number: BW119266
  • IVISbrite A549 Red F-luc Bioluminescent Tumor Cell line

    This cell line has very bright bioluminescence, emitting at least 25,000 photons/cell/sec in vitro. The exact number will vary depending on imaging and culturing conditions.

    By emitting intensified, longer wavelength light that is significantly brighter than other firefly luciferases, our bioluminescent oncology cell lines allow you to visualize and monitor the growth of deep tissue tumors in vivo.

    After the cells are injected into an appropriate mouse model, the optimized Red F-luc luciferase enables more sensitive in vivo optical detection with less tissue attenuation so you can detect tumor development earlier, and monitor tumor growth and metastases in both subcutaneous and orthotopic models.

    • Organism: Human
    • Tissue: Lung
    • Disease: Carcinoma
    • Optical Reporter: Red F-luc
  • Brand
    Cancer Model
    Imaging Modality
    Luciferase Classification
    Quantity in a Package Amount
    2.0 Vials
    Shipping Conditions
    Shipped in Dry Ice
    Unit Size
    2 vials each containing 1 million cells